Medicinova Inc financial data

Symbol
MNOV on Nasdaq
Location
4275 Executive Square, Suite 300, La Jolla, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.33K % -23.2%
Debt-to-equity 6.44 % +16.2%
Return On Equity -24.9 % -41.7%
Return On Assets -23.4 % -40.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49M shares 0%
Common Stock, Shares, Outstanding 49M shares 0%
Entity Public Float 68.6M USD -37.3%
Common Stock, Value, Issued 49K USD 0%
Weighted Average Number of Shares Outstanding, Basic 49M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 49M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 123K USD
Research and Development Expense 7M USD +6.06%
General and Administrative Expense 5.88M USD +16.6%
Operating Income (Loss) -13.4M USD -11.6%
Net Income (Loss) Attributable to Parent -12M USD -16.7%
Earnings Per Share, Basic 0 USD/shares -19%
Earnings Per Share, Diluted 0 USD/shares -19%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 32.6M USD -23%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 32.9M USD -23.9%
Property, Plant and Equipment, Net 12.9K USD -58%
Operating Lease, Right-of-Use Asset 224K USD -44.6%
Goodwill 9.6M USD 0%
Other Assets, Noncurrent 19K USD 0%
Assets 47.6M USD -18.1%
Accounts Payable, Current 746K USD +5.33%
Employee-related Liabilities, Current 786K USD -4.66%
Contract with Customer, Liability, Current 522K USD
Liabilities, Current 3.34M USD +28.5%
Deferred Income Tax Liabilities, Net 202K USD 0%
Operating Lease, Liability, Noncurrent 74.4K USD -70.8%
Other Liabilities, Noncurrent 74.4K USD -70.8%
Liabilities 3.61M USD +18.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -127K USD -2.42%
Retained Earnings (Accumulated Deficit) -436M USD -2.83%
Stockholders' Equity Attributable to Parent 44M USD -20.2%
Liabilities and Equity 47.6M USD -18.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.78M USD +2.19%
Net Cash Provided by (Used in) Investing Activities 39.9K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 49M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.79M USD +1.88%
Deferred Tax Assets, Valuation Allowance 84.4M USD +1.24%
Deferred Tax Assets, Gross 85.6M USD +1.15%
Operating Lease, Liability 255K USD -44.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12M USD -16.7%
Lessee, Operating Lease, Liability, to be Paid 273K USD -46.4%
Property, Plant and Equipment, Gross 428K USD -12.5%
Operating Lease, Liability, Current 181K USD -10.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 17.3K USD -91.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 206K USD -8.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 18.2K USD -65.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 71.2M USD +1.69%
Unrecognized Tax Benefits 2.7M USD +69.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Operating Lease, Payments 236K USD -10.5%
Depreciation, Depletion and Amortization 5.18K USD -3.23%
Share-based Payment Arrangement, Expense 913K USD +32.2%